Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years. Results from an RCT including 511 subjects

Infectious Diseases

Volumn 48, Issue 11-12, 2016, Pages 823-828

  Jorde, Rolf ^a,b   Sollid, Stina T ^a,b   Svartberg, Johan ^a,b   Joakimsen, Ragnar M ^a,b   Grimnes, Guri ^a,b   Hutchinson, Moira Y S ^c  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

Diabetes; respiratory infection; urinary tract infection; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; ERGOCALCIFEROL; PLACEBO; VITAMIN D;

ADULT; ARTICLE; BRONCHITIS; CALCIUM BLOOD LEVEL; COMMON COLD; CONTROLLED STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFECTION PREVENTION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; URINARY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; CHEMOPROPHYLAXIS; MIDDLE AGED; PROCEDURES; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

ADULT; AGED; CHEMOPREVENTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VITAMIN D;

EID: 84978471380     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.1080/23744235.2016.1201853     Document Type: Article

References (28)

1. H.F.DeLuca Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S–1696S.
2. W.E.Stumpf, M.Sar, F.A.Reid,. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206:1188–1190.
3. A.K.Bhalla, E.P.Amento, T.L.Clemens,. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells:presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57:1308–1310.
4. J.H.White Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76:3837–3843.
5. A.R.Martineau, K.A.Wilkinson, S.M.Newton,. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria:the role of cathelicidin LL-37. J Immunol. 2007;178:7190–7198.
6. M.D.Kearns, J.A.Alvarez, N.Seidel,. Impact of vitamin D on infectious disease. Am J Med Sci. 2015;349:245–262.
7. A.Juzeniene, L.W.Ma, M.Kwitniewski,. The seasonality of pandemic and non-pandemic influenzas:the roles of solar radiation and vitamin D. Int J Infect Dis. 2010;14:e1099–e1105.
8. D.P.Hayes Influenza pandemics, solar activity cycles, and vitamin D. Med Hypotheses. 2010;74:831–834.
9. W.B.Grant, E.Giovannucci The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol. 2009;1:215–219.
10. S.T.Sollid, M.Y.Hutchinson, O.M.Fuskevåg,. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. 2014;37:2123–2131.
11. R.Jorde, S.T.Sollid, J.Svartberg,. Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab. 2016;101:1647–1655.
12. C.J.Nolan, P.Damm, M.Prentki Type 2 diabetes across generations:from pathophysiology to prevention and management. Lancet. 2011;378:169–181.
13. W.E.van der Starre, C.van Nieuwkoop, U.Thomson,. Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia:a case control study. PLoS One. 2015;10:e0121302.
14. M.Tekin, C.Konca, V.Celik,. The association between vitamin d levels and urinary tract infection in children. Horm Res Paediatr. 2015;83:198–203.
15. W.Nseir, M.Taha, H.Nemarny,. The association between serum levels of vitamin D and recurrent urinary tract infections in premenopausal women. Int J Infect Dis. 2013;17:e1121–e1124.
16. C.P.Vaughan, T.M.Johnson, 2nd, P.S.Goode,. Vitamin D and lower urinary tract symptoms among US men:results from the 2005-2006 National Health and Nutrition Examination Survey. Urology. 2011;78:1292–1297.
17. N.Caretta, S.Vigili de Kreutzenberg, U.Valente,. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes. Andrology. 2015;3:1062–1067.
18. Y.E.Kwon, H.Kim, H.J.Oh,. Vitamin D deficiency is an independent risk factor for urinary tract infections after renal transplants. Medicine (Baltimore). 2015;94:e594.
19. M.Chromek, Z.Slamová, P.Bergman,. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med. 2006;12:636–641.
20. O.Hertting, Å.Holm, P.Lüthje,. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One. 2010;5:e15580.
21. D.D.Bikle Vitamin D and the immune system:role in protection against bacterial infection. Curr Opin Nephrol Hypertens. 2008;17:348–352.
22. J.C.Gallagher, L.M.Smith, V.Yalamanchili Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause. 2014;21:1173–1180.
23. S.S.Badalian, P.F.Rosenbaum Vitamin D and pelvic floor disorders in women:results from the National Health and Nutrition Examination Survey. Obstet Gynecol. 2010;115:795–803.
24. L.Adorini, G.Penna, B.Fibbi,. Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann N Y Acad Sci. 2010;1193:146–152.
25. A.R.Kristal, K.B.Arnold, J.M.Schenk,. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia:results from the prostate cancer prevention trial. Am J Epidemiol. 2008;167:925–934.
26. E.Colli, P.Rigatti, F.Montorsi,. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia:a randomized clinical trial. Eur Urol. 2006;49:82–86.
27. A.C.Ross, J.E.Manson, S.A.Abrams,. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine:what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58.
28. E.Theodoratou, I.Tzoulaki, L.Zgaga,. Vitamin D and multiple health outcomes:umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.